|
× |
 |
Levetiracetam for Treatment-Refractory Posttraumatic Stress Disorder. PDF |
$40.00 |
|
$40.00 |
|
× |
|
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder PDF |
$0.00 |
|
$0.00 |
|
× |
|
Microstructural Differences in the Corpus Callosum in Patients With Bipolar Disorder and Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Deipnophobia: A Case of Social Anxiety Masquerading as Eating Issues PDF |
$40.00 |
|
$40.00 |
|
× |
|
Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
A 12-Week Single-Blind Trial of Quetiapine for the Treatment of Mood Symptoms in Adolescents at High Risk for Developing Bipolar I Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Dose-Outcome Analysis of Risperidone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Challenges and Opportunities in Teaching Psychopharmacology During Residency Training PDF |
$40.00 |
|
$40.00 |
|
× |
|
Time Trends in Incidence Rates of Diagnosed Attention-Deficit/Hyperactivity Disorder Across 16 Years in a Nationwide Danish Registry Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Dissociative Disorders Among Inpatients With Drug or Alcohol Dependency PDF |
$40.00 |
|
$40.00 |
|
× |
|
New-Onset Psychosis Secondary to COVID-19 Infection PDF |
$40.00 |
|
$40.00 |
|
|
